Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?-Reference-Cited by-同舟云学术

Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?

Published:2022-09-05 Issue:4 Volume:37 Page:581-583
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Chaudhary Varun^ORCID,Bhandari Mohit,Wykoff Charles C.,Sivaprasad Sobha,Thabane Lehana,Kaiser Peter,Sarraf David,Bakri Sophie J.,Garg Sunir J.,Singh Rishi P.,Holz Frank G.,Wong Tien Y.,Guymer Robyn H.,

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-022-02221-0.pdf

Reference40 articles.

1. Arevalo JF, Lasave AF, Wu L, Acón D, Berrocal MH, Diaz-Llopis M, et al. Intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration: 5-year results of the Pan-American Collaborative Retina Study Group. Retina. 2016;36:859–67.

2. Corazza P, D’Alterio FM, Kabbani J, Alam MM, Mercuri S, Orlans HO, et al. Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study. BMC Ophthalmol. 2021;21:1–8.

3. Ciulla TA, Huang F, Westby K, Williams DF, Zaveri S, Patel SC. Real-world outcomes of anti–vascular endothelial growth factor therapy in neovascular age-related macular degeneration in the United States. Ophthalmol Retin. 2018;2:645–53.

4. Talks JS, Lotery AJ, Ghanchi F, Sivaprasad S, Johnston RL, Patel N, et al. First-year visual acuity outcomes of providing aflibercept according to the VIEW study protocol for age-related macular degeneration. Ophthalmology. 2016;123:337–43.

5. van Asten F, Evers‐Birkenkamp KU, van Lith‐Verhoeven JJ, de Jong‐Hesse Y, Hoppenreijs VP, Hommersom RF, et al. A prospective, observational, open‐label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age‐related macular degeneration. Acta Ophthalmologica. 2015;93:126–33.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity;Ophthalmology Retina;2024-09